179 related articles for article (PubMed ID: 18257810)
1. Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis.
Sherif AM; Yoshida H; Maruyama Y; Yamamoto H; Yokoyama K; Hosoya T; Kawakami M; Nakayama M
Ther Apher Dial; 2008 Feb; 12(1):33-41. PubMed ID: 18257810
[TBL] [Abstract][Full Text] [Related]
2. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients.
Honda K; Nitta K; Horita S; Tsukada M; Itabashi M; Nihei H; Akiba T; Oda H
Adv Perit Dial; 2003; 19():169-75. PubMed ID: 14763056
[TBL] [Abstract][Full Text] [Related]
3. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment.
Yamamoto R; Nakayama M; Hasegawa T; Miwako N; Yamamoto H; Yokoyami K; Ikeda M; Kato N; Hayakawa H; Takahashi H; Otsuka Y; Kawaguchi Y; Hosoya T
Adv Perit Dial; 2002; 18():131-4. PubMed ID: 12402604
[TBL] [Abstract][Full Text] [Related]
4. [Morpho-functional study of peritoneum in peritoneal dialysis].
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
G Ital Nefrol; 2003; 20(2):160-5. PubMed ID: 12746801
[TBL] [Abstract][Full Text] [Related]
5. Changes in peritoneal membrane after continuous ambulatory peritoneal dialysis--a histopathological study.
Bertoli SV; Barone MT; Vago L; Bonetto S; De Vecchi A; Scalamogna A; Barbiano di Belgiojoso G
Adv Perit Dial; 1999; 15():28-31. PubMed ID: 10682067
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients.
Sherif AM; Nakayama M; Maruyama Y; Yoshida H; Yamamoto H; Yokoyama K; Kawakami M
Nephrol Dial Transplant; 2006 Jun; 21(6):1675-81. PubMed ID: 16554330
[TBL] [Abstract][Full Text] [Related]
7. Morpho-functional study of peritoneum in peritoneal dialysis patients.
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
J Nephrol; 2003; 16(3):373-8. PubMed ID: 12832736
[TBL] [Abstract][Full Text] [Related]
8. Experience of 100 surgical cases of encapsulating peritoneal sclerosis: investigation of recurrent cases after surgery.
Kawanishi H; Moriishi M; Tsuchiya S
Adv Perit Dial; 2006; 22():60-4. PubMed ID: 16983941
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002.
Nakayama M; Yamamoto H; Ikeda M; Hasegawa T; Kato N; Takahashi H; Otsuka Y; Yokoyama K; Yamamoto R; Kawaguchi Y; Hosoya T
Adv Perit Dial; 2002; 18():144-8. PubMed ID: 12402607
[TBL] [Abstract][Full Text] [Related]
10. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients.
Ekim M; Fitöz S; Yagmurlu A; Ensari A; Yüksel S; Acar B; Ozçakar ZB; Kendirli T; Bingöler B; Yalçinkaya F
Nephrology (Carlton); 2005 Aug; 10(4):341-3. PubMed ID: 16109078
[TBL] [Abstract][Full Text] [Related]
11. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.
Hendriks MP; de Sévaux RG; Hilbrands LB
Neth J Med; 2008; 66(7):269-74. PubMed ID: 18663253
[TBL] [Abstract][Full Text] [Related]
12. Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in Japan.
Yamamoto H; Nakayama M; yamamoto R; Otsuka Y; Takahashi H; Kato N; Hayakawa H; Hasegawa T; Ikeda M; Yokoyama K; Kawaguchi Y; Mukai H; Hosoya T
Adv Perit Dial; 2002; 18():135-8. PubMed ID: 12402605
[TBL] [Abstract][Full Text] [Related]
13. Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan.
Nakamoto H; Kawaguchi Y; Suzuki H
Adv Perit Dial; 2002; 18():119-23. PubMed ID: 12402602
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients.
Alscher DM; Braun N; Biegger D; Fritz P
Am J Kidney Dis; 2007 Mar; 49(3):452-61. PubMed ID: 17336707
[TBL] [Abstract][Full Text] [Related]
15. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E
Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012
[TBL] [Abstract][Full Text] [Related]
16. Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis.
Moriishi M; Kawanishi H
Adv Perit Dial; 2008; 24():56-9. PubMed ID: 18986002
[TBL] [Abstract][Full Text] [Related]
17. [Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal].
Nakayama M; Ikeda M; Katoh N; Hayakawa H; Numata M; Otsuka Y; Yamamoto R; Yamamoto H; Yokoyama K; Kubo H; Kawaguchi Y; Hosoya T
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):396-401. PubMed ID: 12073625
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
[TBL] [Abstract][Full Text] [Related]
19. Pathology of encapsulating peritoneal sclerosis.
Honda K; Oda H
Perit Dial Int; 2005 Apr; 25 Suppl 4():S19-29. PubMed ID: 16300269
[TBL] [Abstract][Full Text] [Related]
20. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
